Search Results - "Casper, Ellie"

Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies by Stuver, Robert, Drill, Esther, Ganesan, Nivetha, Baron, Kelsey, Casper, Ellie, Chang, Tiffany, Desai, Sanjal H., Falade, Ayo S, Galasso, Natasha, Herrera, Alex F., Mei, Matthew G., Merryman, Reid W., Micallef, Ivana, Shah, Harsh, Moskowitz, Alison

“…Background: For patients with relapsed and refractory (R/R) classical Hodgkin lymphoma (HL), the standard of care remains salvage therapy followed by…”
Get full text

Reduced Dose Brentuximab Vedotin for Mycosis Fungoides Appears to Prolong Response Duration By Balancing Efficacy and Tolerability by Munayirji, Brittney, Khan, Niloufer, Myskowski, Patricia, Geller, Shamir, Noor, Sarah, Kheterpal, Meenal Kapoor, Davey, Theresa, Hancock, Helen, Perez, Leslie, Miller, Tayler, Brutus, Jamila, Ganesan, Nivetha, Chang, Tiffany, Mangiaracina, Gianna, Patel, Richa, Galasso, Natasha, Casper, Ellie, Ghione, Paola, Stuver, Robert, Epstein-Peterson, Zachary D., Pulitzer, Melissa, Khodadoust, Michael S., Kim, Youn H., Horwitz, Steven M., Moskowitz, Alison

“…Introduction: Brentuximab vedotin (BV) is one of the most active systemic agents for treating mycosis fungoides (MF); however, treatment duration and the…”
Get full text

Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant by Baron, Kelsey, Drill, Esther, Ganesan, Nivetha, Merryman, Reid W., Mei, Matthew G., Stuver, Robert, Desai, Sanjal H., Falade, Ayo S, Iyengar, Siddharth, Micallef, Ivana, Ng, Lay She, Casper, Ellie, Galasso, Natasha, Tao, Randa, Dandapani, Savita, Ng, Andrea, Yahalom, Joachim, Herrera, Alex F., Moskowitz, Alison, Shah, Harsh

“…Introduction There is no prospective data to guide the utilization of peri-transplant radiation (PTRT) in patients with relapsed or refractory (R/R) classical…”
Get full text

Distinct Patterns of CD4+ and CD8+ T-Cell Clonal Expansion Enable Broad Clinical Responses to Pembrolizumab + GVD in Patients with Relapsed Hodgkin Lymphoma by Wills, Beatriz, Rahman, Jahan, Ganesan, Nivetha, Shah, Gunjan L., Noy, Ariela, Schoder, Heiko, Yahalom, Joachim, Kumar, Anita, Falchi, Lorenzo, Hamlin, Paul A., Palomba, Maria Lia, Johnson, William, Intlekofer, Andrew M., Caron, Philip, Davey, Theresa, Hancock, Helen, Galasso, Natasha, Munayirji, Brittney, Hui Lin, Ya, Santarosa, Alayna, Casper, Ellie, Pongas, Georgio, Zelenetz, Andrew D., Moskowitz, Craig H., Salles, Gilles, Vardhana, Santosha A, Moskowitz, Alison

“…Introduction: Classical Hodgkin lymphoma (cHL) is characterized by immune dysregulation, with recurrent amplifications of the 9p24 locus encoding several genes…”
Get full text

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma by Wills, Beatriz, Ganesan, Nivetha, Shah, Gunjan L., Wong, Phillip, Argyropoulos, Kimon V., Sen, Filiz, Dogan, Ahmet, Straus, David J., Noy, Ariela, Kumar, Anita, Schoder, Heiko, Michaud, Laure, Palomba, Maria Lia, Falchi, Lorenzo, Lahoud, Oscar B, Hamlin, Paul A., Yahalom, Joachim, Johnson, William T., Zelenetz, Andrew D., Intlekofer, Andrew M., Owens, Colette, Batlevi, Connie Lee, Hamilton, Audrey, Caron, Philip C, Horwitz, Steven M., Galasso, Natasha, Hancock, Helen, Davey, Theresa, Santarosa, Alayna, Perez, Leslie, Capadona, Charisse, Munayirji, Brittney, Matasar, Matthew J., Pongas, Georgios, Casper, Ellie, Salles, Gilles, Moskowitz, Craig H., Vardhana, Santosha, Moskowitz, Alison J.

Get full text